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Editorial on the Research Topic
Nutrition and Metabolism in Rheumatic Diseases
Every day, we eat, digest and absorb nutrients through our gastrointestinal mucosa into circulation
resulting in a cascade of biochemical responses within cells to finally produce energy. On the other
hand, skewed or insufficient nutritional intake, decreased physical activity and/or dysregulated
metabolic responses may lead to a perpetuation, deterioration or even occurrence of inflammation
or chronic diseases. Recent accumulation of investigations points to an essential role of nutrition
and metabolic regulations in the pathogenesis and pathophysiology of many diseases, including
rheumatic disorders. In particular, the concept of “immunometabolism” has been recently
introduced showing how metabolic pathways would modulate functions of immune cells. Further,
a potential contribution of adipocytes, or of visceral fat in systemic or local inflammation and
rheumatic arthropathies has been actively discussed. This Research Topic, aimed to focus on the
potential role of nutrition and metabolism in rheumatic diseases. It consists of a set of five papers—
two mini-reviews, one research original paper, and finally a case report followed by a hypothesis
theory paper.
Guerreiro et al. present a mini review “Diet, Microbiota, and Gut Permeability—The Unknown
Triad in Rheumatoid Arthritis” acknowledge and review the relationship between rheumatoid
arthritis and distinct gut microbiota composition in comparison to healthy individuals. In the end
they elicit critical questions that remain to be elucidated: Are the clinical benefits associated with the
selective growth of a “healthy gut microbiota.” What is the relevance of intestinal permeability in
this equation since both diet andmicrobiota seem to change its functionality? How the microbiome
fluctuates in relation to diet, and how disease activity may be influenced by changes in diet,
microbiota or diet-intestinal microbiota equilibrium. These questions show that large room for
research exist in this field.
Masuko reviewed “A Potential Benefit of “Balanced Diet” for Rheumatoid Arthritis.” In
this paper Masuko discussed that rheumatoid arthritis patients should be advised that a
balanced diet that includes appropriate amounts of carbohydrate, especially dietary fiber, is
important for maintaining the symbiosis of intestinal flora, which could be beneficial for
preventing autoimmunity.
In an original paper “Chemerin and PEDF Are Metaflammation-Related Biomarkers
of Disease Activity and Obesity in Rheumatoid Arthritis” Tolusso et al. aimed to
determine whether PEDF and Chemerin are biomarkers of inflammation related
to fat accumulation in RA and to investigate whether weight loss associates with
clinical disease improvement through the modification of fat-related biomarkers in
overweight/obese RA with low-moderate disease. They concluded that PEDF and Chemerin
arose as biomarkers of obesity and metaflammation respectively, providing a link
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between chronic inflammation and excess of body weight in RA.
Therefore, BMI reduction of at least 5% in obese RA allowed
better disease control without modifying RA treatment.
Finally, the last two papers from Lattanzio and Imbesi
focused on the relationship between fibromyalgia symptomatic
control and diet strategy. The first one, “Fibromyalgia Syndrome:
A Case Report on Controlled Remission of Symptoms by a
Dietary Strategy” reported a case of symptoms’ improvement
in a fibromyalgia patient after a diet allowing a proper
absorption of tryptophan assumed with food, while avoiding,
or at least minimizing the presence of interfering non-absorbed
molecules, such as fructose and sorbitol. The authors suggest the
implementation of a clinical trial to validate this strategy in a
large scale. In the last paper Lattanzio develop a hypothesis and
theory paper “Fibromyalgia Syndrome: A Metabolic Approach
Grounded in Biochemistry for the Remission of Symptoms,”
where she developed the theory of the relationship between a diet
with low tryptophan absorption and fibromyalgia symptoms.
This set of papers show how this field is in an emergent
phase and how much research is needed in this area
of knowledge.
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